StockGuru Alert: Announcing Our Latest Profile – Oncolin Therapeutics (OCOL)
Oncolin Therapeutics, Inc. (OTCBB: OCOL) is a biopharmaceutical company focused on developing drugs which interfere with the key mechanisms of cancer tumor development. The company engages in the discovery, development and commercialization of novel selective anticancer therapies. The company has a lead drug for brain cancer in preclinical development licensed from the MD Anderson Cancer Center. Oncolin is focused on the development of this drug to clinical development with an IND scheduled to be filed in approximately 18 months [ Investigational New Drug (application to the FDA) ]. The company also has a robust pipeline of oncology research programs that…